We are live on
!
Find out more
ZCM
Zebra Capital Management Portfolio holdings
AUM
$20M
1-Year Est. Return
2.24%
This Fund
S&P 500
This Quarter
Est. Return
+18.5%
1 Year Est. Return
+2.24%
3 Year Est. Return
+142.1%
5 Year Est. Return
+107.07%
10 Year Est. Return
+252.16%
AUM
$90.8M
AUM Growth
+$12M
(+15%)
Cap. Flow
+$4.91M
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
278
New
115
Increased
17
Reduced
37
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$2.15M |
| 2 |
Kelly Services Class A
KELYA
|
+$1.94M |
| 3 |
ESGR
Enstar Group
ESGR
|
+$1.61M |
| 4 |
LCI Industries
LCII
|
+$1.56M |
| 5 |
Upbound Group
UPBD
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WD-40
WDFC
|
+$1.47M |
| 2 |
Corcept Therapeutics
CORT
|
+$1.23M |
| 3 |
Veracyte
VCYT
|
+$1.22M |
| 4 |
Castle Biosciences
CSTL
|
+$1.03M |
| 5 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$965K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.12% |
| 2 | Industrials | 15.8% |
| 3 | Financials | 14.75% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Technology | 12.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Veracyte
VCYT
$3.7B
| $202K | 0.22% |
3,762
-21,267
| -85% | -$1.22M |
|
|
MCBC
152
DELISTED
Macatawa Bank Corp
MCBC
| $181K | 0.2% |
18,215
-90,315
| -83% | -$830K |
|
|
TRUE
153
DELISTED
TrueCar
TRUE
| $174K | 0.19% |
36,420
-28,311
| -44% | -$140K |
|
154
Information Services Group
III
$199M
| $152K | 0.17% |
34,621
+14,229
| +70% | +$54.6K |
|
|
WSR
155
DELISTED
Whitestone REIT
WSR
| $134K | 0.15% |
+13,813
| New | +$124K |
|
156
Precigen
PGEN
$2.24B
| $133K | 0.15% |
+19,332
| New | +$163K |
|
157
LSI Industries
LYTS
$859M
| $121K | 0.13% |
14,188
-8,882
| -39% | -$82.7K |
|
158
Riverview Bancorp
RVSB
$107M
| $120K | 0.13% |
17,289
-109,690
| -86% | -$673K |
|
|
ATRS
159
DELISTED
Antares Pharma, Inc.
ATRS
| $117K | 0.13% |
28,438
-115,888
| -80% | -$502K |
|
|
ADMS
160
DELISTED
Adamas Pharmaceuticals
ADMS
| $112K | 0.12% |
+23,400
| New | +$122K |
|
|
OSG
161
DELISTED
Overseas Shipholding Group Inc.
OSG
| $106K | 0.12% |
+51,240
| New | +$113K |
|
162
Harrow
HROW
$1.45B
| $103K | 0.11% |
15,281
-42,781
| -74% | -$351K |
|
|
DRRX
163
DELISTED
DURECT Corp
DRRX
| $94K | 0.1% |
+4,765
| New | +$107K |
|
164
SIGA Technologies
SIGA
$235M
| $94K | 0.1% |
+14,459
| New | +$98K |
|
|
BDSI
165
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $92K | 0.1% |
23,622
-120,619
| -84% | -$498K |
|
166
Stereotaxis
STXS
$126M
| $82K | 0.09% |
12,190
-54,352
| -82% | -$323K |
|
|
RVLP
167
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $79K | 0.09% |
+24,384
| New | +$100K |
|
|
SBBP
168
DELISTED
Strongbridge Biopharma plc.
SBBP
| $66K | 0.07% |
+24,039
| New | +$72.5K |
|
169
KORU Medical Systems
KRMD
$189M
| $39K | 0.04% |
+11,183
| New | +$48.4K |
|
170
Alarm.com
ALRM
$2.71B
| – | – |
-6,780
| Closed | -$701K |
|
|
ALX
171
Alexander's
ALX
$1.3B
| – | – |
-1,383
| Closed | -$384K |
|
172
AppFolio
APPF
$6.38B
| – | – |
-1,464
| Closed | -$264K |
|
173
Accuray
ARAY
$32M
| – | – |
-19,901
| Closed | -$83K |
|
174
Astec Industries
ASTE
$1.16B
| – | – |
-5,191
| Closed | -$300K |
|
175
A10 Networks
ATEN
$2.13B
| – | – |
-72,266
| Closed | -$713K |
|
Similar funds
CM
NPAM
6C
SCU
FFG
KE
GFT
CCM
Zebra Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Zebra Capital Management held 278 positions worth $90.8M, up 15% from $78.8M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Zebra Capital Management deployed $4.91M of net new capital in Q1 2021, opening 115 new positions and adding to 17 existing holdings. Its largest new stake was Emergent Biosolutions: 20,957 shares worth $1.95M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Veracyte, an estimated $1.22M trimmed.
- Zebra Capital Management's largest Q1 2021 buy was Emergent Biosolutions: 20,957 shares worth $1.95M.
- Zebra Capital Management added most to Rush Enterprises Class A in Q1 2021, an estimated $819K increase.
- Zebra Capital Management's biggest Q1 2021 reduction was Veracyte, cutting an estimated $1.22M.
- Zebra Capital Management fully exited WD-40 in Q1 2021, selling an estimated $1.47M.
- Zebra Capital Management's ten largest holdings make up 18% of its $90.8M portfolio in Q1 2021.
- Zebra Capital Management opened 115 new positions and closed 109 in Q1 2021.
- Zebra Capital Management's portfolio value rose 15% quarter-over-quarter to $90.8M.
Based on Zebra Capital Management's 13F filing for Q1 2021, filed 17 May 2021.